ArticleBMC cancer2015

Combined treatment of Nimotuzumab and rapamycin is effective against temozolomide-resistant human gliomas regardless of the EGFR mutation status.

Dawn Q Chong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.